Breaking News Instant updates and real-time market news.

QRVO

Qorvo

$111.97

-0.91 (-0.81%)

, SWKS

Skyworks

$119.61

0.125 (0.10%)

05:12
01/10/20
01/10
05:12
01/10/20
05:12

Qorvo upgraded to Buy from Neutral at Mizuho

Mizuho analyst Vijay Rakesh upgraded Qorvo (QRVO) to Buy from Neutral with a price target of $125, up from $80. The stock closed Thursday down 96c to $111.96. The analyst upgraded radio frequency suppliers Qorvo and Skyworks Solutions (SWKS) as he sees "meaningful upside" from an improving 5G handset outlook. RF content per handset is estimated to rise 50%-60% versus 4G, Rakesh tells investors in a research note. The analyst believes share catalysts should come from the 3GSM in mid-February, which he notes should see multiple 5G handset launches, a potential for a Huawei settlement in the second half of 2020 as China trade tensions cool, and multiple new Apple (AAPL) iPhone models including 5G.

QRVO

Qorvo

$111.97

-0.91 (-0.81%)

SWKS

Skyworks

$119.61

0.125 (0.10%)

AAPL

Apple

$309.70

6.61 (2.18%)

  • 23

    Jan

  • 28

    Jan

QRVO Qorvo
$111.97

-0.91 (-0.81%)

12/16/19
BNCH
12/16/19
NO CHANGE
Target $127
BNCH
Buy
Qorvo price target raised to $127 from $100 at Benchmark
Benchmark analyst Ruben Roy increased his price target on Qorvo (QRVO) shares to $127 from $100 as 5G handset forecasts for 2020 continue to improve. The analyst, who expects Qorvo's cash flows and margins both to improve over the next few years, also said he views Broadcom's (AVGO) recent comments on its wireless business as a potential longer-term positive for Qorvo. Roy keeps a Buy rating on Qorvo shares.
12/16/19
JPMS
12/16/19
NO CHANGE
JPMS
Overweight
JPMorgan sees more Semi upside in 2020, top pick is Broadcom
Although semiconductor stocks have outperformed in 2019, further upside exists in 2020 as the industry growth rates inflect positively and drive the positive earnings revision cycle, JPMorgan analyst Harlan Sur tells investors in a research note. The analyst's overall top pick in semis is Broadcom (AVGO) on the company's "underappreciated diversification," "strong" free cash flow and dividend growth. He also highlights Overweight-rated Nvidia (NVDA), Intel (INTC) and Micron Technology (MU) on their "strong datacenter exposure," Qorvo (QRVO) and Marvell (MRVL) as key 5G plays, as well as Texas Instruments (TXN) and Microchip (MCHP) on improving industrial/cyclical trends. In small caps, Sur's top pick is Inphi (IPHI) and in semiconductor equipment his pick is KLA-Tencor (KLAC).
12/23/19
MSCO
12/23/19
NO CHANGE
MSCO
Overweight
Morgan Stanley would buy Broadcom shares on any asset sale headline volatility
Morgan Stanley analyst Craig Hettenbach noted that The Wall Street Journal reported last week that Broadcom (AVGO) is considering selling its RF business in a deal that could be valued at $10B, which he thinks "seems low" relative to Skyworks (SWKS) and Qorvo (QRVO). He would use any volatility related to news of potential strategic actions to buy the stock, highlighting that he doesn't believes the shares are given credit for the fact that Broadcom has expanded gross margins by nearly 1000 basis points,and operating margin by 700 basis points, over the last three years. Hettebach, who estimates that a sale of RF could be dilutive to EPS by low single digits, but also thinks such a sale could free up added capital to pursue accretive software acquisitions, keeps an Overweight rating and $367 price target on Broadcome shares.
01/06/20
BNCH
01/06/20
NO CHANGE
BNCH
Benchmark names Alibaba, Nvidia, Comcast among best ideas for first half
Benchmark analysts named their Best Ideas for the first half of 2020 across their coverage, naming Altice USA (ATUS), Tencent (TCEHY), Activision Blizzard (ATVI), Alibaba (BABA), Comcast (CMCSA), Coherent (COHR), Champions Oncology (CSBR), Electronic Arts (EA), 1-800-Flowers.com (FLWS), Flexion (FLXN), Mitek Systems (MITK), Nephros (NEPH), Nvidia (NVDA), Onto Innovation (ONTO), Qorvo (QRVO), Sinclair Broadcast (SBGI), Staar Surgical (STAA), TPI Composites (TPIC), Tabula Rasa HealthCare (TRHC), Varonis (VRNS) and Youngevity (YGYI).
SWKS Skyworks
$119.61

0.125 (0.10%)

12/09/19
BOFA
12/09/19
UPGRADE
BOFA
Buy
Skyworks, Qorvo double-upgraded to Buy at BofA/Merrill on 5G opportunity
BofA/Merrill analyst Vivek Arya double-upgraded Skyworks (SWKS) and Qorvo (QRVO) to Buy from Underperform, also raising his price targets to $122 from $92 and $130 from $80 respectively. The analyst cites the unfolding opportunity of 5G technology, calling its adoption "one of the more compelling and investable themes in semis" that will drive an "exponential" growth in components required in the upgrade. Arya further sees the companies' radio frequency chips as a "critical enabling technology" to monetize spectrum and boost the handset battery life, adding that these stocks have also lagged the semiconductor index SOX since 2015.
01/10/20
MZHO
01/10/20
UPGRADE
Target $132
MZHO
Buy
Skyworks upgraded to Buy from Neutral at Mizuho
Mizuho analyst Vijay Rakesh upgraded Skyworks Solutions (SWKS) to Buy from Neutral with a price target of $132, up from $90. The analyst upgraded the radio frequency suppliers as he sees "meaningful upside" from an improving 5G handset outlook. RF content per handset is estimated to rise 50%-60% versus 4G, Rakesh tells investors in a research note. The analyst believes share catalysts should come from the 3GSM in mid-February, which he notes should see multiple 5G handset launches, a potential for a Huawei settlement in the second half of 2020 as China trade tensions cool, and multiple new Apple (AAPL) iPhone models including 5G.
12/09/19
12/09/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Qorvo (QRVO) and Skyworks (SWKS) double upgraded to Buy from Underperform at BofA/Merrill. 2. Fate Therapeutics (FATE) upgraded to Outperform from Market Perform at Wells Fargo with analyst Jim Birchenough citing this weekend's update for the company's iPSC-derived NK-cell therapeutics pipeline, initial data for iPSC NKcell therapies FT500 and FT516, and updated comments on CD19 CAR-NK therapeutic FT596. 3. Wingstop (WING) upgraded to Conviction Buy from Buy at Goldman Sachs with analyst Katherine Fogertey saying while the shares are up over 30% over the past year, they have lagged the S&P 500 by over 30% since August 22 and now trade at a discount to peers. 4. Huntsman (HUN) and Fortive (FTV) upgraded to Buy from Neutral at Citi. 5. Dow Inc. (DOW) and Kraton (KRA) upgraded to Buy from Hold at SunTrust. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
AAPL Apple
$309.70

6.61 (2.18%)

01/07/20
GSCO
01/07/20
INITIATION
Target $17
GSCO
Sell
Cerence initiated with a Sell at Goldman Sachs
Goldman Sachs analyst Christopher Merwin initiated coverage of Cerence (CRNC) with a Sell rating and $17 price target. While Cerence has established itself as a leading provider of artificial intelligence-powered automotive virtual assistants over the past 20 years, larger technology companies like Google (GOOG) and Apple (AAPL) are offering free substitute products for connected services that offer more advanced AI-technology, search functionality, and native smartphone integration, Merwin tells investors in a research note. The analyst believes this competition could pressure Cerence's connected business over time.
01/09/20
BERN
01/09/20
INITIATION
Target $127
BERN
Underperform
Bernstein starts Spotify at Underperform on 'overly optimistic' expectations
Bernstein analyst Todd Juenger last night initiated coverage of Spotify (SPOT) with an Underperform rating and $127 price target. The analyst believes consensus growth expectations are "overly optimistic." Paying subscribers in Spotify's home market Sweden only make up 40%, an indicator of the ceiling for paid subs in a given market, Juenger tells investors in a research note. Spotify also faces increased competition from Apple (AAPL) and Amazon (AMZN), Juenger tells investors in a research note. The analyst assumes Spotify will only cede a small amount of market share in developed markets, "despite the entrance of these deep-pocketed tech behemoths," which he believes is a "generous assumption."
01/09/20
JEFF
01/09/20
NO CHANGE
Target $350
JEFF
Buy
Apple price target raised to $350 from $285 at Jefferies
Earlier, Jefferies analyst Kyle McNealy raised his price target on Apple (AAPL) shares to $350 from $285, telling investors that his analysis of U.S. store foot traffic data and global web traffic indicates that Apple saw a strong finish to calendar 2019. He is also seeing early evidence that increased device subsidy competition among wireless operators in the U.S. is starting, driven by T-Mobile (TMUS) amid its 600 MHz network build out. While he is keeping his iPhone unit estimates unchanged, McNealy is removing tariffs from his model, driving his price target increase.

TODAY'S FREE FLY STORIES

TLGT

Teligent

$0.40

-0.0025 (-0.62%)

15:53
01/18/20
01/18
15:53
01/18/20
15:53
Conference/Events
Teligent to hold a special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

AYTU

Aytu BioScience

$0.80

0.0014 (0.18%)

15:48
01/18/20
01/18
15:48
01/18/20
15:48
Conference/Events
Aytu BioScience to hold a special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

DVA

DaVita

$79.45

0.43 (0.54%)

15:32
01/18/20
01/18
15:32
01/18/20
15:32
Conference/Events
DaVita to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

TSM

TSMC

$58.58

-0.18 (-0.31%)

09:16
01/18/20
01/18
09:16
01/18/20
09:16
Periodicals
Taiwan tech stocks can ignore China's bluster for now, Barron's says »

China's government…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KKR

KKR

$31.20

0.7 (2.30%)

, APO

Apollo Global

$50.35

1.26 (2.57%)

09:03
01/18/20
01/18
09:03
01/18/20
09:03
Periodicals
KKR undervalued compared with peers, Barron's says »

KKR (KKR) gained 50% last…

KKR

KKR

$31.20

0.7 (2.30%)

APO

Apollo Global

$50.35

1.26 (2.57%)

ARES

Ares Management

$37.29

0.47 (1.28%)

BX

Blackstone

$60.79

0.62 (1.03%)

CG

Carlyle Group

$33.30

0.36 (1.09%)

HLNE

Hamilton Lane

$67.25

-0.02 (-0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

  • 30

    Jan

  • 31

    Jan

  • 31

    Jan

  • 04

    Feb

  • 04

    Feb

  • 05

    Feb

  • 13

    Feb

  • 17

    Feb

  • 26

    Feb

SPCE

Virgin Galactic

$15.65

0.685 (4.58%)

, TWNK

Hostess Brands

$14.03

0.02 (0.14%)

08:56
01/18/20
01/18
08:56
01/18/20
08:56
Periodicals
'Blank-check' companies hot on Wall Street, Barron's says »

More than a quarter of…

SPCE

Virgin Galactic

$15.65

0.685 (4.58%)

TWNK

Hostess Brands

$14.03

0.02 (0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 04

    Mar

GOOG

Alphabet

$1,480.28

28.34 (1.95%)

, NFLX

Netflix

$339.56

0.89 (0.26%)

08:47
01/18/20
01/18
08:47
01/18/20
08:47
Periodicals
Peacock's pricing might be 'killer feature,' Barron's says »

This week, Peacock…

GOOG

Alphabet

$1,480.28

28.34 (1.95%)

NFLX

Netflix

$339.56

0.89 (0.26%)

CMCSK

Comcast

$0.00

(0.00%)

CMCSA

Comcast

$47.48

0.62 (1.32%)

GOOGL

Alphabet Class A

$1,479.12

29.29 (2.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

  • 22

    Jan

  • 23

    Jan

  • 03

    Feb

  • 03

    Feb

  • 10

    Feb

JWN

Nordstrom

$40.34

-0.15 (-0.37%)

, WMT

Walmart

$114.93

-0.96 (-0.83%)

08:36
01/18/20
01/18
08:36
01/18/20
08:36
Periodicals
Casper IPO highlights tech's promise, troubles, Barron' says »

Mattresses have been…

JWN

Nordstrom

$40.34

-0.15 (-0.37%)

WMT

Walmart

$114.93

-0.96 (-0.83%)

CSPR

Casper Sleep

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

  • 18

    Feb

BA

Boeing

$324.11

-7.89 (-2.38%)

, DDAIF

Daimler AG

$0.00

(0.00%)

08:12
01/18/20
01/18
08:12
01/18/20
08:12
On The Fly
Week in Review: How Trump's policies moved stocks »

Catch up on the top…

BA

Boeing

$324.11

-7.89 (-2.38%)

DDAIF

Daimler AG

$0.00

(0.00%)

FCAU

Fiat Chrysler

$13.76

-0.14 (-1.01%)

VWAGY

Volkswagen

$0.00

(0.00%)

FSLR

First Solar

$53.51

-0.42 (-0.78%)

AAPL

Apple

$318.66

3.33 (1.06%)

DQ

Daqo New Energy

$53.61

-0.025 (-0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jan

  • 29

    Jan

SPOT

Spotify

$148.20

-3.59 (-2.37%)

18:15
01/17/20
01/17
18:15
01/17/20
18:15
Periodicals
Spotify in talks to acquire The Ringer, WSJ reports »

Spotify is in discussions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

CE

Celanese

$117.54

-0.53 (-0.45%)

18:00
01/17/20
01/17
18:00
01/17/20
18:00
Hot Stocks
Celanese announces acetyl intermediates price increases »

Celanese Corporation will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jan

BYND

Beyond Meat

$109.20

-1.16 (-1.05%)

17:58
01/17/20
01/17
17:58
01/17/20
17:58
Periodicals
Beyond Meat rival gets green light in Canada, The Star says »

Impossible Foods, a maker…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DBD

Diebold

$11.09

-0.49 (-4.23%)

17:42
01/17/20
01/17
17:42
01/17/20
17:42
Periodicals
Breaking Periodicals news story on Diebold »

Diebold Nixdorf divests…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IEF

iShares 7-10 Year Treasury Bond ETF

$111.28

-0.13 (-0.12%)

, SHY

iShares 1-3 Year Treasury Bond

$84.73

-0.005 (-0.01%)

17:32
01/17/20
01/17
17:32
01/17/20
17:32
General news
Weekly CFTC Commitment of Traders highlights »

2-YEAR U.S. TREASURY net…

IEF

iShares 7-10 Year Treasury Bond ETF

$111.28

-0.13 (-0.12%)

SHY

iShares 1-3 Year Treasury Bond

$84.73

-0.005 (-0.01%)

SPY

SPDR S&P 500 ETF Trust

$331.98

1.08 (0.33%)

SLV

iShares Silver Trust

$16.82

0.04 (0.24%)

GLD

SPDR Gold Shares

$146.59

0.29 (0.20%)

FXE

Euro Currency Trust

$105.10

-0.43 (-0.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UBSFY

Ubisoft

$0.00

(0.00%)

17:32
01/17/20
01/17
17:32
01/17/20
17:32
Periodicals
Ubisoft to restructure editorial team after difficult 2019, VGC reports »

Ubisoft intends to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 18

    Feb

IMVT

Immunovant

$17.04

-0.01 (-0.06%)

17:27
01/17/20
01/17
17:27
01/17/20
17:27
Syndicate
Breaking Syndicate news story on Immunovant »

Immunovant files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TBLT

ToughBuilt

$0.33

-0.0255 (-7.11%)

17:20
01/17/20
01/17
17:20
01/17/20
17:20
Syndicate
ToughBuilt files to sell common stock, no amount given »

Maxim acted as sole book…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYO

Myomo

$0.32

0.0062 (1.98%)

17:18
01/17/20
01/17
17:18
01/17/20
17:18
Conference/Events
Myomo to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

SRRA

Sierra Oncology

$0.40

-0.02 (-4.76%)

17:14
01/17/20
01/17
17:14
01/17/20
17:14
Conference/Events
Sierra Oncology to host virtual special shareholder meeting »

Virtual Special…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jan

SRNE

Sorrento Therapeutics

$4.26

-0.15 (-3.40%)

17:10
01/17/20
01/17
17:10
01/17/20
17:10
Syndicate
Breaking Syndicate news story on Sorrento Therapeutics »

Sorrento Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKER

Akers Biosciences

$3.45

-0.1 (-2.82%)

17:01
01/17/20
01/17
17:01
01/17/20
17:01
Hot Stocks
Akers Biosciences reaches settlement agreements on two derivative actions »

Akers Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ECA

Encana

$4.09

-0.18 (-4.22%)

16:40
01/17/20
01/17
16:40
01/17/20
16:40
Hot Stocks
Encana receives court approval for reorganization »

Encana Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

MBRX

Moleculin Biotech

$0.96

0.0122 (1.29%)

16:38
01/17/20
01/17
16:38
01/17/20
16:38
Syndicate
Breaking Syndicate news story on Moleculin Biotech »

Moleculin Biotech files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VOD

Vodafone

$20.07

-0.225 (-1.11%)

, BT

BT Group

$0.00

(0.00%)

16:37
01/17/20
01/17
16:37
01/17/20
16:37
Periodicals
BT, Vodafone consider urging PM Johnson not to ban Huawei in U.K., Reuters says »

BT Group (BT) and…

VOD

Vodafone

$20.07

-0.225 (-1.11%)

BT

BT Group

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
01/17/20
01/17
16:30
01/17/20
16:30
Options
Preliminary option volume of 28.7M today »

Preliminary option volume…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.